TGTX News Today | Why did TG Therapeutics stock go down …

2 days ago · TG Therapeutics, Inc. (NASDAQ:TGTX - Get Free Report) CFO Sean A. Power sold 11,337 shares of the business's stock in a transaction that occurred on Friday, January 3rd. …

4%
OFF

TG Therapeutics (NASDAQ:TGTX) Trading Down 2.4% - Here's Why …

2 weeks from now

Dec 31, 2024 · TG Therapeutics, Inc. (NASDAQ:TGTX - Get Free Report)'s share price fell 2.4% on Tuesday . The company traded as low as $30.61 and last traded at $30.68. 366,002 shares …

marketbeat.com

82%
OFF

After Plunging -9.82% In 4 Weeks, Here's Why The Trend Might …

2 weeks from now

Apr 30, 2024 · TG Therapeutics (TGTX) has been on a downward spiral lately with significant selling pressure. After declining 9.8% over the past four weeks, the stock looks well positioned …

yahoo.com

40%
OFF

What's Going On With TG Therapeutics Stock Today?

2 weeks from now

Aug 1, 2023 · TG Therapeutics Inc (NASDAQ:TGTX) shares are down over 40%. The company reported Q2 FY23 Briumvi net sales of $16 million in the U.S., with total net revenue of …

businessinsider.com

60%
OFF

Why TG Therapeutics Stock Is Falling Today - Benzinga

2 weeks from now

Nov 30, 2021 · TGTX Price Action: TG Therapeutics has traded as high as $56.74 and as low as $21.05 over a 52-week period. The stock was down 41.60% at $13.65. TGTX TG …

benzinga.com

50%
OFF

Why Is TG Therapeutics (TGTX) Stock Down 50% Today?

2 weeks from now

Aug 1, 2023 · Following a disappointing outcome for the second quarter, shares of biotechnology firm TG Therapeutics (NASDAQ:TGTX) suffered a catastrophic loss.Specializing in Briumvi — …

investorplace.com

4%
OFF

TG Therapeutics (NASDAQ:TGTX) Trading Down 2.4% – Here’s …

2 weeks from now

Dec 31, 2024 · TG Therapeutics, Inc. (NASDAQ:TGTX – Get Free Report) fell 2.4% during trading on Tuesday . The stock traded as low as $30.61 and last traded at $30.68. 366,002 …

americanbankingnews.com

$10.00
OFF

Bank Of America Securities Reaffirms Their Sell Rating On TG ...

2 weeks from now

1 day ago · Bank of America Securities analyst Alec Stranahan maintained a Sell rating on TG Therapeutics (TGTX – Research Report) today and set a price target of $10.00. The …

businessinsider.com

5%
OFF

TG Therapeutics (TGTX) Moves 7.5% Higher: Will This Strength Last?

2 weeks from now

19 hours ago · TG Therapeutics (TGTX Quick Quote TGTX - Free Report) shares ended the last trading session 7.5% higher at $29.74. The jump came on an impressive volume with a higher …

zacks.com

40%
OFF

Why TG Therapeutics Is Plunging More Than 40% Today

2 weeks from now

Nov 30, 2021 · Shares of biopharma outfit TG Therapeutics (TGTX-6.82%) are down to the tune of 43.4% as of 11:38 a.m. ET Tuesday after the ... Why TG Therapeutics Stock Is Crashing …

fool.com

8%
OFF

What's Going On With TG Therapeutics Stock Tuesday?

2 weeks from now

1 day ago · TGTX Price Action: TG Therapeutics shares were up 7.8% at $29.85 at the time of publication, according to Benzinga Pro. Photo: Shutterstock. Market News and Data brought to …

benzinga.com

9%
OFF

Why TGTX Stock Is Rallying Today - Yahoo Finance

2 weeks from now

23 hours ago · The shares of drug maker TG Therapeutics (TGTX) are climbing 9% today after the firm preannounced higher-than-expected 2024 revenue from its multiple sclerosis drug, …

yahoo.com

30%
OFF

TG Therapeutics Stock Just Rallied 30%: What Happened? - MSN

2 weeks from now

TG Therapeutics Inc (NASDAQ: TGTX) is up 30% on Wednesday even though it reported a wider-than-expected per-share loss for its fiscal first quarter. The biotech stock is being …

msn.com

75%
OFF

Why TG Therapeutics Stock Is Crushing It Today - The Motley Fool

2 weeks from now

Nov 1, 2023 · TG Therapeutics' (TGTX 2.75%) stock was crushing it on Wednesday. Shares of the biopharmaceutical company were soaring 36.4% higher as of 11:32 a.m. ET. Shares of the …

fool.com

82%
OFF

Why Is Tg Therapeutics Inc (TGTX) Stock Down 6.82% Today?

2 weeks from now

Jul 13, 2023 · Shares of Tg Therapeutics Pharmaceuticals (TGTX) dropped by 7.97% from $7.78 to $7.16 in the trading on Monday, October 9, 2023. The reason why TGTX stock down is due …

stockscan.io

9%
OFF

Why TGTX Stock Is Rallying Today - MSN

2 weeks from now

The shares of drug maker TG Therapeutics (TGTX) are climbing 9% today after the firm preannounced higher-than-expected 2024 revenue from its multiple sclerosis drug, Briumvi. …

msn.com

$12.84
OFF

TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Bought By

2 weeks from now

4 days ago · TG Therapeutics, Inc. has a 52-week low of $12.84 and a 52-week high of $36.84. The company has a market capitalization of $4.50 billion, a P/E ratio of -288.77 and a beta of …

marketbeat.com

9%
OFF

TG Therapeutics (NASDAQ:TGTX) Given "Buy" Rating At HC …

2 weeks from now

19 hours ago · NBC Securities Inc. grew its holdings in shares of TG Therapeutics by 58.9% during the third quarter. NBC Securities Inc. now owns 1,309 shares of the biopharmaceutical …

marketbeat.com

FAQs about TGTX News Today | Why did TG Therapeutics stock go down … Coupon?

What happened to TG Therapeutics (tgtx) in Q2?

The drugmaker delivered a couple of surprises in Q2. Shares of TG Therapeutics ( TGTX -7.97%) were crashing 50.4% lower as of 11:12 a.m. ET on Tuesday. The huge sell-off came after the company announced its second-quarter results. Total net product revenue was $16 million in the second quarter. ...

Should you buy TG Therapeutics Inc (tgtx)?

TG Therapeutics Inc (TGTX) reports over 230% year-over-year revenue growth, raises full-year guidance, and outlines future growth strategies. AI stocks Meta Platforms and Oracle lead the parade of top five stocks to watch near buy points this week. Netflix, TG Therapeutics and GoDaddy also make the cut. ...

Why are TG Therapeutics (tgtx) shares climbing 9% today?

The shares of drug maker TG Therapeutics (TGTX) are climbing 9% today after the firm preannounced higher-than-expected 2024 revenue from its multiple sclerosis drug, Briumvi. Briumvi's 2024 Revenue Exceeded TG's Guidance The company estimated today that its 2024 revenue from the MS treatment had come in at $310 million. ...

Why did tgtx stock fall 50% in Q2?

Specializing in Briumvi — a therapeutic for the treatment of relapsing forms of multiple sclerosis ( MS) — Q2 represented the first full quarter of the drug’s sales. While scientifically compelling, Briumvi may not have lived up to excessive hype, resulting in TGTX stock falling 50%. ...

Did tgtx buy back shares in Q2'24?

The company announced that credit facility and a share buyback with Q2'24 earnings. The company bought back 92,301 shares for $2.1M in Q3'24. As of November 4, 2024, there were 155,665,334 shares of TGTX's common stock outstanding. TGTX has a market cap of $4.5B ($28.88). ...

Should you buy tgtx (tgtx) stock in 2028?

Fundamentally, the global MS therapeutics market size features a wide canvas for TGTX stock. According to research firm Mordor Intelligence, this sector may reach a valuation of $28.66 billion at the end of this year. By 2028, the segment should be valued at $33.98 billion, representing a compound annual growth rate (CAGR) of 3.46%. ...